Pheniramine 22.75mg/ml Injection Franchise in Ahmedabad

Antihistamine Therapy Supplier in Mumbai

Phenimin Injection Distributor in Delhi

Allergy & Hypersensitivity Injection Franchise Opportunity in Bangalore

Injectable Antihistamine Stockist in Hyderabad
Pheniramine 22.75mg/ml Export & Manufacturing in Chandigarh

Home/Products /pheniramine-22-75mg-ml-injection

Phenimin Injection

Composition : Pheniramine (22.75mg/ml) Injection

Dosage Form : Injection

Packaging Type : Ampule

Packaging : 10x5x2ml

Price : ₹1/-

Phenimin Injection contains Pheniramine 22.75mg/ml, an antihistamine indicated for the management of allergic reactions, urticaria, rhinitis, conjunctivitis, and other hypersensitivity conditions. It helps in relieving itching, redness, and swelling associated with allergic responses.

Pheniramine works by blocking H1 histamine receptors, thereby preventing histamine-mediated allergic symptoms and providing rapid relief. Its injectable formulation allows precise dosing and fast onset of action for acute conditions.

For distributors and healthcare suppliers, Phenimin Injection is a high-demand antihistamine therapy product, widely used in hospitals, clinics, emergency care, and allergy specialty centers. The prevalence of allergic disorders ensures consistent market demand throughout the year.

Adding Phenimin Injection to your allergy and hypersensitivity therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its fast-acting injectable formulation, prescriber trust, and broad clinical use make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Phenimin Injection contains Pheniramine 22.75mg/ml, an antihistamine indicated for the management of allergic reactions, urticaria, rhinitis, conjunctivitis, and other hypersensitivity conditions. It helps in relieving itching, redness, and swelling associated with allergic responses.

Pheniramine works by blocking H1 histamine receptors, thereby preventing histamine-mediated allergic symptoms and providing rapid relief. Its injectable formulation allows precise dosing and fast onset of action for acute conditions.

For distributors and healthcare suppliers, Phenimin Injection is a high-demand antihistamine therapy product, widely used in hospitals, clinics, emergency care, and allergy specialty centers. The prevalence of allergic disorders ensures consistent market demand throughout the year.

Adding Phenimin Injection to your allergy and hypersensitivity therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its fast-acting injectable formulation, prescriber trust, and broad clinical use make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include drowsiness, dizziness, dry mouth, or mild gastrointestinal discomfort. Rare but serious side effects include severe hypersensitivity reactions, hypotension, or respiratory depression. Immediate medical attention is required if severe symptoms occur.

Phenimin Injection is indicated for the treatment of allergic conditions such as urticaria, angioedema, hay fever, drug allergies, and anaphylactic reactions (as part of combination therapy), as prescribed by a healthcare professional.

Phenimin Injection should be administered only under medical supervision. Patients with a history of glaucoma, urinary retention, or cardiovascular disease should inform their doctor before use. Caution is advised when operating machinery or driving due to possible sedation.

Store Phenimin Injection in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use the injection beyond the expiry date printed on the vial.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation